Literature DB >> 2591986

Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers.

E D Srivastava1, M B Hallett, J Rhodes.   

Abstract

1. Neutrophils play a role in the pathogenesis of ulcerative colitis. Most of the patients with ulcerative colitis are non-smokers. 2. Neutrophil function was examined in healthy males, five smokers and five non-smokers, measuring production of oxygen free radicals by chemiluminescence. 3. The chemiluminescence was examined in the presence of nicotine and its main metabolite cotinine in various concentrations. 4. 10 mM nicotine inhibited production of oxygen free radicals (90.2% +/- 11.6) compared with controls (P less than 0.001), as did the same concentration of cotinine (58.9% +/- 34.2), (P less than 0.05). 5. 1 mM solutions had no effect and 3 mM nicotine was required to achieve 50% inhibition. 6. Smokers and non-smokers did not differ. 7. Since plasma concentrations of nicotine after a cigarette are only between 5 and 15 mM, the observed effects of nicotine and cotinine in much higher pharmacological concentrations in this system are unlikely to be of clinical relevance in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591986     DOI: 10.1177/096032718900800605

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  9 in total

Review 1.  Role of smoking in inflammatory bowel disease: implications for therapy.

Authors:  G A Thomas; J Rhodes; J T Green; C Richardson
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

2.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

Authors:  Alvin V Terry; Jerry J Buccafusco; R Foster Schade; Leah Vandenhuerk; Patrick M Callahan; Wayne D Beck; Elizabeth J Hutchings; James M Chapman; Pei Li; Michael G Bartlett
Journal:  Biochem Pharmacol       Date:  2012-01-08       Impact factor: 5.858

4.  Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.

Authors:  Jie Gao; Bao-Ling Adam; Alvin V Terry
Journal:  Bioorg Med Chem Lett       Date:  2014-02-14       Impact factor: 2.823

5.  Smoking and ulcerative colitis: a community study.

Authors:  E D Srivasta; R G Newcombe; J Rhodes; P Avramidis; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

6.  Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.

Authors:  Ailed Cruz-Collazo; Jean F Ruiz-Calderon; Hector Picon; Luis D Borrero-Garcia; Irmaris Lopez; Linette Castillo-Pichardo; Maria Del Mar Maldonado; Jorge Duconge; Julia I Medina; Marvin J Bayro; Eliud Hernández-O'Farrill; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  Mol Cancer Ther       Date:  2021-10-04       Impact factor: 6.009

Review 7.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.

Authors:  George E Barreto; Alexander Iarkov; Valentina Echeverria Moran
Journal:  Front Aging Neurosci       Date:  2015-01-09       Impact factor: 5.750

8.  Anxiolytic, Promnesic, Anti-Acetylcholinesterase and Antioxidant Effects of Cotinine and 6-Hydroxy-L-Nicotine in Scopolamine-Induced Zebrafish (Danio rerio) Model of Alzheimer's Disease.

Authors:  Razvan Stefan Boiangiu; Marius Mihasan; Dragos Lucian Gorgan; Bogdan Alexandru Stache; Lucian Hritcu
Journal:  Antioxidants (Basel)       Date:  2021-02-01

Review 9.  Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions.

Authors:  Xiaoying Tan; Kent Vrana; Zheng-Ming Ding
Journal:  Front Behav Neurosci       Date:  2021-10-21       Impact factor: 3.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.